Options
NPC1 as a Modulator of Disease Severity and Viral Entry of SARSCoV- 2
Journal
Current Molecular Medicine
ISSN
1566-5240
Date Issued
2021
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Abstract
<jats:sec>
<jats:title />
<jats:p>The COVID-19 plague is hitting mankind. Several viruses, including SARS-CoV-1,
MERS-CoV, EBOV, and SARS-CoV-2, use the endocytic machinery to enter the cell. Genomic
variants in NPC1, which encodes for the endo-lysosomal Niemann-Pick type C1 protein, restricts
the host-range of viruses in bats and susceptibility to infections in humans. Lack of NPC1 and its
pharmacological suppression inhibits many viral infections including SARS-CoV-1 and Type I Feline
Coronavirus Infection. Antiviral effects of NPC1-inhibiting drugs for COVID-19 treatment should be
explored.</jats:p>
</jats:sec>
<jats:title />
<jats:p>The COVID-19 plague is hitting mankind. Several viruses, including SARS-CoV-1,
MERS-CoV, EBOV, and SARS-CoV-2, use the endocytic machinery to enter the cell. Genomic
variants in NPC1, which encodes for the endo-lysosomal Niemann-Pick type C1 protein, restricts
the host-range of viruses in bats and susceptibility to infections in humans. Lack of NPC1 and its
pharmacological suppression inhibits many viral infections including SARS-CoV-1 and Type I Feline
Coronavirus Infection. Antiviral effects of NPC1-inhibiting drugs for COVID-19 treatment should be
explored.</jats:p>
</jats:sec>
Project(s)
Subjects
covid-19
;
sars-cov-2
;
niemann-pick c1
;
modifier gene
;
drug repurposing
;
virus
;
infection
;
antiviral agents
;
covid-19
;
drug repositioning
;
humans
;
intracellular signaling peptides and proteins
;
sars-cov-2
;
severity of illness index
;
virus internalization
;
1 benzylpiperazine derivative
;
amphophile
;
angiotensin converting enzyme 2
;
antisense oligonucleotide
;
clomifene
;
diamide
;
hydroxychloroquine
;
npc intracellular cholesterol transporter 1
;
terconazole
;
antivirus agent
;
npc1 protein, human
;
signal peptide
;
antiviral activity
;
article
;
chikungunya virus
;
cholesterol metabolism
;
coronavirus disease 2019
;
dengue virus
;
disease severity
;
drug repositioning
;
ebolavirus
;
endocytosis
;
feline coronavirus
;
filovirus
;
gene silencing
;
genetic susceptibility
;
hepatitis c
;
host range
;
human
;
human immunodeficiency virus
;
lysosome
;
lysosome storage disease
;
middle east respiratory syndrome coronavirus
;
modifier gene
;
multiple sclerosis
;
niemann pick disease
;
nonhuman
;
plague
;
protein function
;
severe acute respiratory syndrome coronavirus 2
;
single nucleotide polymorphism
;
virus entry
;
virus infection
;
west nile virus
;
zika fever
;
zika virus
;
drug therapy
;
pathophysiology
;
physiology
;
severity of illness index
;
virology
;
virus entry